tesofensine and tirzepatide Tesofensine for Weight Loss: Dosage
Description
They affect up to 60 percent of adults and 7 percent of children and teens
Gut check on diabesity: leveraging gut mechanisms for the treatment of type 2 diabetes and obesity
Patients who experience vomiting should stay well hydrated
Every person who reports that their migraines improved on a GLP-1 agonist adds to the signal that researchers use to justify clinical trials
But "stronger" is misleading because they work through different mechanisms
The slightly higher serious adverse event rate with tirzepatide in SURPASS-2 has not raised safety concerns in subsequent, larger trials
